Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor.
Li WQ, Yu HY, Li YM, Wang X, He J, Yan HZ, Yang DH, Wu XJ, Hou LJ, Liu HM, et al. Biochem Biophys Res Commun. 2014 Apr 18; 446(4):1261-7. Epub 2014 Mar 29.